I think people must just be realising the high probability of Ph2b success. Next SAS read-out is surely the nail in the coffin. Dosage and protocols very similar to trial so you'd expect results to be the same. Huge market, it works, reduces requirement for steroids as well as opiates. You'd expect a successful trial result to be shortly followed by partnership (milestone payments and ongoing royalties), or a straight takeover at huge premiums. No shares will be leaving my account until all the cards are on the table. Potential upside is just too tempting to not be all in. All IMO
FA bagger potential, page-26
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.055(20.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 33.5¢ | 27.5¢ | $1.328M | 4.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 152597 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
